atezolizumab plus bevacizumab plus carboplatin plus paclitaxel
atezolizumab plus SoC
avelumab alone
avelumab plus pegylated liposomal doxorubicin
avelumab plus SoC
nivolumab based treatment
Comparator:
vs bevacizumab plus carboplatin and paclitaxel; vs pegylated liposomal doxorubicin; vs Standard of Care (SoC); vs rucaparib; vs placebo plus SoC;
Risk of bias:
low;
some concerns;
high;
NA;